|
RowasaDrug - Rowasa The trade name of the product as shown on the labeling.
Dosage -
SUPPOSITORY; RECTAL
Active Ingredient(s) -
Mesalamine
Strength -
500MG
Applicant -
SOLVAY
New Drug Application (NDA) Number -
019919
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Dec 18, 1990
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Solvay Pharmaceuticals
Rowasa
Pentasa 250mg Capsule, Extended Release; Oral
Pentasa 500mg Capsule, Extended Release; Oral Mesalamine 4gm/60ml Enema; Rectal Mesalamine 4gm/60ml Enema; Rectal Rowasa 4gm/60ml Enema; Rectal Canasa 1gm Suppository; Rectal Canasa 500mg Suppository; Rectal Rowasa 500mg Suppository; Rectal Merrem I.V. 500mg/vial Injectable; Injection Mersalyl-theophylline 100mg/ml;50mg/ml Injectable; Injection NewDrugInformation |